Jazz Pharmaceuticals plc Cash Flow Reinvestment Rate
Jazz Pharmaceuticals plc cash flow reinvestment rate. Jazz Pharmaceuticals plc (J7Z) has a Cash Flow Reinvestment Rate of 0.59x as of March 2026, reinvesting €239.70 Million (capex €19.70 Million plus investments €220.00 Million) from operating cash flow of €408.20 Million. Explore debt repayment capacity of Jazz Pharmaceuticals plc to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Jazz Pharmaceuticals plc (2013–2025)
Cash flow reinvestment rate of Jazz Pharmaceuticals plc from 2013 to 2025. Historical reinvestment intensity for Jazz Pharmaceuticals plc across 13 annual periods. Explore J7Z capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Jazz Pharmaceuticals plc Cash Flow Reinvestment Rate by Year (2013–2025)
Jazz Pharmaceuticals plc cash flow reinvestment rate by year from 2013 to 2025. Year-by-year capital reinvestment analysis for Jazz Pharmaceuticals plc. For the full cash flow conversion analysis, see how efficiently does Jazz Pharmaceuticals plc generate cash.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | €680.03 Million | €1.36 Billion | €209.75 Million | ▲ +37.8% |
| 2024 | 0.36x | €508.19 Million | €1.40 Billion | €48.07 Million | ▲ +143.8% |
| 2023 | 0.15x | €163.06 Million | €1.09 Billion | €42.96 Million | ▲ +531.4% |
| 2022 | 0.02x | €30.08 Million | €1.27 Billion | €29.05 Million | ▼ -98.3% |
| 2021 | 1.41x | €1.10 Billion | €778.51 Million | €27.64 Million | ▲ +92.5% |
| 2020 | 0.73x | €657.68 Million | €899.65 Million | €15.00 Million | ▲ +425.4% |
| 2019 | 0.14x | €108.03 Million | €776.40 Million | €40.13 Million | ▼ -66.4% |
| 2018 | 0.41x | €331.29 Million | €798.90 Million | €20.37 Million | ▲ +56.2% |
| 2017 | 0.27x | €183.95 Million | €693.09 Million | €28.95 Million | ▼ -91.9% |
| 2016 | 3.26x | €1.93 Billion | €592.39 Million | €181.58 Million | ▲ +1612.7% |
| 2015 | 0.19x | €101.23 Million | €531.94 Million | €35.96 Million | ▼ -23.7% |
| 2014 | 0.25x | €101.62 Million | €407.61 Million | €36.35 Million | ▼ -4.4% |
| 2013 | 0.26x | €75.25 Million | €288.43 Million | €9.98 Million | — |